In AML, overexpressed HOXA10 functions as an autocrine stimulator to increase the cell population of myeloid progenitor cells via the transforming growth factor-beta (TGF-β) signaling pathway (Shah et al. 2011). The gene discussed is HOXA10; the disease is acute myeloid leukemia.